Form 4 for EVMN Evommune, Inc.
Accepted 2026-06-03 20:02:34 ET · period of report 2026-06-01 · accession 0002092017-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-03 20:02 | 2026-06-01 | EVMN | Patel Jeegar Pravinkumar | CSO | M - OptEx | $3.84 | +13.5K | 63.1K | +27% | +$51.9K |
| DT | 2026-06-03 20:02 | 2026-06-01 | EVMN | Patel Jeegar Pravinkumar | CSO | S - Sale+OE | $22.74 | -16.7K | 46.4K | -26% | -$379.5K |
| DT | 2026-06-03 20:02 | 2026-06-01 | EVMN | Patel Jeegar Pravinkumar | CSO | M - OptEx | $0.00 | -13.5K | 29.3K | -32% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-01 | M | A | 13,512 | $3.84 | 63,090 | D | — | — | (F1) The transactions were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026. |
| 2 | Common | Common Stock | 2026-06-01 | S | D | 16,687 | $22.74 | 46,403 | D | — | — | (F1) The transactions were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026. (F2) The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $22.50 to $23.35 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2026-06-01 | M | D | 13,512 | $0.00 | 29,330 | D | $3.84 · — to 2033-05-11 | 13,512 Common Stock | (F1) The transactions were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026. (F3) One fourth (1/4) of the shares subject to the option award shall vest on the first anniversary of the grant date and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date. |